Latest news
Lupin bets Biosimilars to cross $100 Mn scale in 3 years; plans in-licensing to innovate India biz - ET PharmaET Pharma · Fri, 07 Aug 2026 14:54:08 GMTSun Pharma banks on specialty drug portfolio, India business to drive growth in FY27 - Moneycontrol.comMoneycontrol.com · Fri, 31 Jul 2026 07:00:00 GMT